Helping adults with Type 1 diabetes use advanced insulin devices more effectively
ONBOARD: OvercomiNg Barriers & Obstacles to Adopting Diabetes Devices
This study is all about helping adults with Type 1 diabetes use advanced tools like continuous glucose monitors and insulin delivery systems more effectively, by finding out what makes it hard for them and offering support and education to make their diabetes management easier and improve their quality of life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10541137 on NIH RePORTER |
What this research studies
This research focuses on improving the adoption and sustained use of advanced diabetes management technologies, such as continuous glucose monitors (CGMs) and closed loop insulin delivery systems, among adults with Type 1 diabetes. The project aims to identify and address the barriers that prevent effective use of these devices through tailored interventions that provide education, support, and problem-solving skills. By empowering patients to overcome physical and social challenges, the research seeks to enhance their overall diabetes management and quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 to 50 who have Type 1 diabetes and are either currently using or considering the use of continuous glucose monitors.
Not a fit: Patients who do not have Type 1 diabetes or those outside the age range of 21 to 50 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diabetes control and improved quality of life for adults with Type 1 diabetes by increasing the effective use of advanced diabetes technologies.
How similar studies have performed: Previous research has shown success in improving diabetes management through behavioral interventions, indicating that this approach has the potential for positive outcomes.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Tanenbaum, Molly Leah — Stanford University
- Study coordinator: Tanenbaum, Molly Leah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.